Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma

British Journal of Cancer

Volumn 109, Issue 1, 2013, Pages 172-183

  Halec, G ^a   Holzinger, D ^a,b   Schmitt, M ^a   Flechtenmacher, C ^b   Dyckhoff, G ^b   Lloveras, B ^c   Hofler D ^a   Bosch, F X ^b   Pawlita, M ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; FORMALDEHYDE; FRACTALKINE; MESSENGER RNA; PARAFFIN; PROTEIN E6; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER RISK; DNA DETERMINATION; DNA EXTRACTION; FEMALE; FROZEN SECTION; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPRODUCIBILITY; RNA TRANSCRIPTION; VIRUS CARCINOGENESIS; VIRUS LOAD; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; VIRAL LOAD;

EID: 84880294033     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.296     Document Type: Article

References (55)

1. Almadori G, Cadoni G, Cattani P, Posteraro P, Scarano E, Ottaviani F, Paludetti G, Maurizi M (1996) Detection of human papillomavirus DNA in laryngeal squamous cell carcinoma by polymerase chain reaction. Eur J Cancer 32A(5): 783-788.
2. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H, Bosch FX (1998) Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58(1): 5-13.
3. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401(1): 70-79.
4. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH (2004) Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96(13): 998-1006.
5. Chernock RD, El-Mofty SK, Thorstad WL, Parvin CA, Lewis Jr JS (2009) HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol 3(3): 186-194.
6. Chernock RD, Wang X, Gao G, Lewis Jr. JS, Zhang Q, Thorstad WL, El-Mofty SK (2012) Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx. Mod Pathol 26(2): 223-231.
7. D'Souza G, Dempsey A (2011) The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med 53(Suppl 1): S5-S11.
8. Duray A, Descamps G, Arafa M, Decaestecker C, Remmelink M, Sirtaine N, Ernoux-Neufcoeur P, Mutijima E, Somja J, Depuydt CE, Delvenne P, Saussez S (2011) High incidence of high-risk HPV in benign and malignant lesions of the larynx. Int J Oncol 39(1): 51-59.
9. Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243(4893): 934-937.
10. El-Mofty SK, Patil S (2006) Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3): 339-345.
11. Garcia-Milian R, Hernandez H, Panade L, Rodriguez C, Gonzalez N, Valenzuela C, Arana MD, Perea SE (1998) Detection and typing of human papillomavirus DNA in benign and malignant tumours of laryngeal epithelium. Acta Otolaryngol 118(5): 754-758.
12. Gorgoulis VG, Zacharatos P, Kotsinas A, Kyroudi A, Rassidakis AN, Ikonomopoulos JA, Barbatis C, Herrington CS, Kittas C (1999) Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 30(3): 274-283.
13. Gottlieb TM, Oren M (1996) p53 in growth control and neoplasia. Biochim Biophys Acta 1287(2-3): 77-102.
14. Gungor A, Cincik H, Baloglu H, Cekin E, Dogru S, Dursun E (2007) Human papilloma virus prevalence in laryngeal squamous cell carcinoma. J Laryngol Otol 121(8): 772-774.
15. Halec G, Schmitt M, Dondog B, Sharkhuu E, Wentzensen N, Gheit T, Tommasino M, Kommoss F, Bosch FX, Franceschi S, Clifford G, Gissmann L, Pawlita M (2012) Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int J Cancer 132(1): 63-71.
16. Hoffmann M, Ihloff AS, Gorogh T, Weise JB, Fazel A, Krams M, Rittgen W, Schwarz E, Kahn T (2010) p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int J Cancer 127(7): 1595-1602.
17. Hoffmann M, Tribius S, Quabius ES, Henry H, Pfannenschmidt S, Burkhardt C, Gorogh T, Halec G, Hoffmann AS, Kahn T, Rocken C, Haag J, Waterboer T, Schmitt M (2012) HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer: how valid is p16INK4A as surrogate marker? Cancer Lett 323(1): 88-96.
18. Holzinger D, Flechtenmacher C, Henfling N, Kaden I, Grabe N, Lahrmann B, Schmitt M, Hess J, Pawlita M, Bosch FX (2013) Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway. Int J Cancer; e-pub ahead of print 2 March 2013; doi:10.1002/ijc.28142.
19. Holzinger D, Schmitt M, Dyckhoff G, Benner A, Pawlita M, Bosch FX (2012) Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. Cancer Res 72(19): 4993-5003.
20. IARC (2011) Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2011 100B: 1-475.
21. Jung AC, Briolat J, Millon R, de Reynies A, Rickman D, Thomas E, Abecassis J, Clavel C, Wasylyk B (2010) Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer 126(8): 1882-1894.
22. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51(23 Pt 1): 6304-6311.
23. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach- Hellweg G, Schmidt D, von Knebel Doeberitz M (2001) Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92(2): 276-284.
24. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14(2): 467-475.
25. Lewis Jr JS, Ukpo OC, Ma XJ, Flanagan JJ, Luo Y, Thorstad WL, Chernock RD (2012) Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas: a tissue microarray study utilizing E6/E7 mRNA in situ hybridization. Histopathology 60(6): 982-991.
26. Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT (2012) Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res 72(19): 5004-5013.
27. Lindquist D, Romanitan M, Hammarstedt L, Nasman A, Dahlstrand H, Lindholm J, Onelov L, Ramqvist T, Ye W, Munck-Wikland E, Dalianis T (2007) Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 1(3): 350-355.
28. Massimi P, Banks L (1997) Repression of p53 transcriptional activity by the HPV E7 proteins. Virology 227(1): 255-259.
29. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, Dalianis T (2002) Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102(2): 152-158.
30. Morshed K, Polz-Dacewicz M, Szymanski M, Polz D (2008) Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation. Eur Arch Otorhinolaryngol 265(Suppl 1): S89-S96.
31. Muscat JE, Wynder EL (1992) Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer. Cancer 69(9): 2244-2251.
32. Pannone G, Sanguedolce F, Santoro A, Fierro P, Panetti M, Fierro D, Maiello F, De Maria S, Giannattasio A, Serpico R, Lo Muzio L, Metafora S, Bufo P (2010) Detection of novel Human papilloma virus type 82 in laryngeal cancer: case report. Auris Nasus Larynx 37(5): 648-650.
33. Perez-Ayala M, Ruiz-Cabello F, Esteban F, Concha A, Redondo M, Oliva MR, Cabrera T, Garrido F (1990) Presence of HPV 16 sequences in laryngeal carcinomas. Int J Cancer 46(1): 8-11.
34. Reimers N, Kasper HU, Weissenborn SJ, Stutzer H, Preuss SF, Hoffmann TK, Speel EJ, Dienes HP, Pfister HJ, Guntinas-Lichius O, Klussmann JP (2007) Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 120(8): 1731-1738.
35. Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O'Sullivan B, Kenny LM, McArthur GA (2010) Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 28(27): 4142-4148.
36. Salam M, Rockett J, Morris A (1995) The prevalence of different human papillomavirus types and p53 mutations in laryngeal carcinomas: is there a reciprocal relationship? Eur J Surg Oncol 21(3): 290-296.
37. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63(6): 1129-1136.
38. Schlecht NF, Brandwein-Gensler M, Nuovo GJ, Li M, Dunne A, Kawachi N, Smith RV, Burk RD, Prystowsky MB (2011) A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol 24(10): 1295-1305.
39. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T (2006) Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 44(2): 504-512.
40. Schmitt M, Dalstein V, Waterboer T, Clavel C, Gissmann L, Pawlita M (2010) Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns. Cancer Res 70(1): 249-256.
41. Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M (2013) Prevalence and viral load of 51 genital human papillomavirus types and three subtypes. Int J Cancer 132(10): 2395-2403.
42. Schmitt M, Dondog B, Waterboer T, Pawlita M (2008) Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5and GP6primers. J Clin Microbiol 46(3): 1050-1059.
43. Si-Mohamed A, Badoual C, Hans S, Pere H, Tartour E, Brasnu D (2012) An unusual human papillomavirus type 82 detection in laryngeal squamous cell carcinoma: case report and review of literature. J Clin Virol 54(2): 190-193.
44. Skyldberg B, Fujioka K, Hellstrom AC, Sylven L, Moberger B, Auer G (2001) Human papillomavirus infection, centrosome aberration, and genetic stability in cervical lesions. Mod Pathol 14(4): 279-284.
45. Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, Meijer CJ, Braakhuis BJ, Leemans CR, Brakenhoff RH (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121(11): 2465-2472.
46. Smith EM, Wang D, Kim Y, Rubenstein LM, Lee JH, Haugen TH, Turek LP (2008) P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol 44(2): 133-142.
47. Sotlar K, Stubner A, Diemer D, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bultmann B (2004) Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol 74(1): 107-116.
48. Syrjanen S, Syrjanen K, Mantyjarvi R, Collan Y, Karja J (1987) Human papillomavirus DNA in squamous cell carcinomas of the larynx demonstrated by in situ DNA hybridization. ORL J Otorhinolaryngol Relat Spec 49(4): 175-186.
49. Torrente MC, Rodrigo JP, Haigentz Jr. M, Dikkers FG, Rinaldo A, Takes RP, Olofsson J, Ferlito A (2011) Human papillomavirus infections in laryngeal cancer. Head Neck 33(4): 581-586.
50. Tsuda H, Hashiguchi Y, Nishimura S, Kawamura N, Inoue T, Yamamoto K (2003) Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm. Gynecol Oncol 91(3): 476-485.
51. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH (2001) Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 93(2): 232-235.
52. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX (2002) Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21(10): 1510-1517.
53. Xie R, Chung JY, Ylaya K, Williams RL, Guerrero N, Nakatsuka N, Badie C, Hewitt SM (2011) Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections. J Histochem Cytochem 59(4): 356-365.
54. Yuen PW, Man M, Lam KY, Kwong YL (2002) Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J Clin Pathol 55(1): 58-60.
55. zur Hausen H (2006) Perspectives of contemporary papillomavirus research. Vaccine 24(Suppl 3): S3/iii-S3/iii.